Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
Vedanta ‘significantly’ reduces headcount to fund lead program
Vedanta Biosciences has “significantly reduced” its headcount to channel its remaining resources to its lead live bacteria cocktail program.
James Waldron
Jan 16, 2026 11:05am
Fierce Biotech Fundraising Tracker 2026: Cytotheryx and Proxima
Jan 16, 2026 9:30am
Sponsored
Servier Sharpens Its Focus on Rare Neurology
Jan 12, 2026 8:00am
ImmunityBio touts 15-month complete response in CAR-NK trial
Jan 16, 2026 9:19am
Sponsored
China’s biotech moment goes global, Zai Lab exec says
Jan 12, 2026 8:00am
RFK Jr. continues overhaul of CDC vaccine panel—Chutes & Ladders
Jan 16, 2026 8:30am